Why Does HNF1B-MODY Affect the Kidneys? Cysts & CKD
At a Glance
HNF1B-MODY can affect the kidneys because the HNF1B gene helps guide kidney development. Gene changes can lead to cysts, structural differences, loss of magnesium in urine, or reduced kidney function before or alongside diabetes, while high blood sugar can add kidney damage over time.
In this answer
5 sections
When you are diagnosed with a form of diabetes like HNF1B-MODY (sometimes called MODY5), it can be surprising when your doctor immediately orders a kidney ultrasound. Most people know that long-term high blood sugar can eventually harm the kidneys. However, HNF1B-MODY is different. In this condition, structural kidney differences are often genetic and developmental—they are not caused by having high blood sugar [1]. Because the HNF1B gene is heavily involved in the early development of multiple organs, a single genetic variation can affect the pancreas, kidneys, and other systems [1][2].
It is important to know that HNF1B-related disease is highly variable [3]. You may have diabetes and kidney findings without having any of the other possible features. Furthermore, because people with HNF1B-MODY still have diabetes, they can still develop ordinary diabetes-related kidney changes over time, making routine monitoring essential [1].
The Kidney Connection
Structural differences in the kidneys are one of the most common features of HNF1B-MODY, affecting many individuals with the condition [1].
- Renal Cysts: Fluid-filled sacs (cysts) in the kidneys are a recognized feature and can sometimes be seen on ultrasounds before birth [4]. However, a normal ultrasound does not rule out HNF1B-related kidney issues.
- Structural Differences: HNF1B variations are an important genetic cause of CAKUT (Congenital Anomalies of the Kidney and Urinary Tract) [5]. This includes anatomical conditions like having only one kidney, a horseshoe-shaped kidney, or abnormally small kidneys [4][6].
- Kidney Function: While an ultrasound checks the structure of your kidneys, blood and urine tests are needed to check how well they filter waste. Some individuals maintain stable kidney function, but others may experience a decline in their estimated glomerular filtration rate (eGFR), leading to chronic kidney disease (CKD) [1]. Because kidney function can decline even before diabetes starts, normal blood sugars do not guarantee your kidneys are unaffected [1][7].
Magnesium Wasting and Electrolytes
The kidneys act as a filtration system, holding onto important minerals. In HNF1B-MODY, the kidneys often struggle to reabsorb magnesium, allowing it to spill into the urine [8].
- Hypomagnesemia: Many people with this condition have abnormally low magnesium levels in their blood (hypomagnesemia) [9]. This is caused by magnesium wasting [10]. While some people experience muscle cramps or fatigue, others have no symptoms. Safety Note: Do not start or change magnesium supplements without your doctor’s guidance. Supplements can cause diarrhea, and incorrect dosing can be unsafe, especially if you have chronic kidney disease [11]. Seek prompt medical attention for severe weakness, fainting, or palpitations.
- Other Imbalances: The kidneys might also lose potassium [8][10]. Additionally, the body may struggle to process uric acid, which increases the risk of developing gout, a painful form of arthritis [2].
Urogenital and Reproductive Anatomy
The HNF1B gene helps guide the development of the urinary and reproductive tracts [12]. Structural differences here are possible, though not guaranteed.
- Reproductive Anatomy: In individuals with female reproductive anatomy, differences known as Müllerian anomalies can occur [12]. This might include a divided uterus (bicornuate uterus) or other anatomical variations [13]. Finding an anomaly does not mean infertility or pregnancy complications are guaranteed, but it may require specialized evaluation if you are planning a family [12].
- Urinary Tract: Differences can include urine flowing backward toward the kidneys (vesicoureteral reflux) or changes in the bladder [7][13]. This may increase the risk of recurrent urinary tract infections.
Other Areas Impacted by HNF1B
- Liver Enzymes: Unexplained elevations in liver enzymes are seen in some people with HNF1B variations [14]. This does not automatically mean the liver is failing, but it warrants clinical interpretation and monitoring.
- Pancreas Structure: The pancreas might be smaller than usual. Some people develop exocrine pancreatic insufficiency, meaning the pancreas doesn’t release enough digestive enzymes [2]. Symptoms like ongoing greasy stools, chronic diarrhea, or unexplained weight loss should prompt a clinical evaluation.
- 17q12 Deletion vs. HNF1B Variant: Your genetic report will specify if you have a spelling variation in just the HNF1B gene, or a larger missing chunk of DNA called a chromosome 17q12 microdeletion [15][7]. Because the 17q12 deletion removes neighboring genes as well, it can sometimes be associated with learning differences or neurodevelopmental features [15].
Building Your Care Team and Monitoring
Because HNF1B can affect multiple systems, your care must be individualized [3]. A referral to a specialist does not mean your diabetes treatment is failing; it is simply a way to look for problems early.
Depending on your specific findings, your care team may include:
- Endocrinologist or Primary Care: To manage diabetes and coordinate your overall care.
- Nephrologist: If you have structural kidney changes, declining eGFR, or significant electrolyte imbalances.
- Urologist or Gynecologist: If you have urinary tract symptoms or are planning a pregnancy.
- Genetic Counselor: To explain how your specific genetic result might affect family planning and whether relatives should receive counseling or testing [16].
Routine Monitoring May Include:
- Kidney Function: Blood tests for eGFR and urine tests for albumin and protein.
- Electrolytes: Blood tests for magnesium, potassium, and uric acid.
- Blood Pressure and Blood Sugar: Standard checks to protect kidney health.
- Imaging: Ultrasounds to check organ structure as recommended by your clinical team.
Common questions in this guide
Why can HNF1B-MODY cause kidney problems?
Can kidney disease occur in HNF1B-MODY before diabetes?
What kidney tests are recommended for HNF1B-MODY?
Does HNF1B-MODY always cause kidney cysts?
Why can HNF1B-MODY cause low magnesium?
Could HNF1B-MODY affect organs besides the kidneys?
What does a nephrologist do for someone with HNF1B-MODY?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my genetic testing show a specific variation within the HNF1B gene, or a larger 17q12 microdeletion?
- 2.Based on my most recent kidney ultrasound, what structural differences are present, and do I need a referral to a nephrologist?
- 3.What are my current eGFR, urine albumin, and serum magnesium levels?
- 4.Given my HNF1B diagnosis, do I need standard diabetes kidney screening in addition to my HNF1B-specific monitoring?
- 5.Who will act as the primary coordinator for my care team to ensure my overall health is being monitored?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects.
Dubois-Laforgue D, Cornu E, Saint-Martin C, et al.
Diabetes care 2017; (40(11)):1436-1443 doi:10.2337/dc16-2462.
PMID: 28420700 - 2
The Clinical Characteristics and Gene Mutations of Maturity-Onset Diabetes of the Young Type 5 in Sixty-One Patients.
Ge S, Yang M, Cui Y, et al.
Frontiers in endocrinology 2022; (13()):911526 doi:10.3389/fendo.2022.911526.
PMID: 35846334 - 3
Genotype and Phenotype Analyses in Pediatric Patients with HNF1B Mutations.
Lim SH, Kim JH, Han KH, et al.
Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072320.
PMID: 32708349 - 4
Variable phenotype in HNF1B mutations: extrarenal manifestations distinguish affected individuals from the population with congenital anomalies of the kidney and urinary tract.
Madariaga L, García-Castaño A, Ariceta G, et al.
Clinical kidney journal 2019; (12(3)):373-379 doi:10.1093/ckj/sfy102.
PMID: 31198537 - 5
HNF1B Transcription Factor: Key Regulator in Renal Physiology and Pathogenesis.
Sánchez-Cazorla E, Carrera N, García-González MÁ
International journal of molecular sciences 2024; (25(19)) doi:10.3390/ijms251910609.
PMID: 39408938 - 6
Characterization of the prenatal renal phenotype associated with 17q12, HNF1B, microdeletions.
Verscaj CP, Velez-Bartolomei F, Bodle E, et al.
Prenatal diagnosis 2024; (44(2)):237-246 doi:10.1002/pd.6424.
PMID: 37632214 - 7
Improving renal phenotype and evolving extra-renal features of 17q12 deletion encompassing the HNF1B gene.
Cleper R, Reches A, Shapira D, et al.
Translational pediatrics 2021; (10(12)):3130-3139 doi:10.21037/tp-21-386.
PMID: 35070826 - 8
Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease.
Kompatscher A, de Baaij JHF, Aboudehen K, et al.
Kidney international 2017; (92(5)):1145-1156 doi:10.1016/j.kint.2017.03.034.
PMID: 28577853 - 9
Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia.
Wang Y, Xiao X, Lin Q, et al.
Journal of diabetes investigation 2024; (15(1)):121-130 doi:10.1111/jdi.14084.
PMID: 37737534 - 10
Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.
van der Made CI, Hoorn EJ, de la Faille R, et al.
American journal of nephrology 2015; (42(1)):85-90 doi:10.1159/000439286.
PMID: 26340261 - 11
De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia.
Stiles CE, Thuraisingham R, Bockenhauer D, et al.
Endocrinology, diabetes & metabolism case reports 2018; (2018()).
PMID: 29576871 - 12
A Diagnosis of Maturity-onset Diabetes of the Young Type 5 Provides Clarity and Broadens Reproductive Options.
Conn JJ, Walsh M, Kane SC, et al.
JCEM case reports 2025; (3(9)):luaf165 doi:10.1210/jcemcr/luaf165.
PMID: 40741598 - 13
HNF1B-MODY (MODY-5): a rare form of diabetes with multisystemic features-two case reports.
Carvalho T, Lavrador M, Saraiva J, Gomes L
Frontiers in endocrinology 2026; (17()):1841040 doi:10.3389/fendo.2026.1841040.
PMID: 42369057 - 14
Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center.
Amaral S, Palha A, Bogalho P, Silva-Nunes J
Diabetology & metabolic syndrome 2023; (15(1)):21 doi:10.1186/s13098-022-00964-0.
PMID: 36793123 - 15
17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5.
Roehlen N, Hilger H, Stock F, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(10)):3601-3610 doi:10.1210/jc.2018-00955.
PMID: 30032214 - 16
Hypertriglyceridemia as a main feature associated with 17q12 deletion syndrome-related hepatocyte nuclear factor 1β-maturity-onset diabetes of the young.
Thewjitcharoen Y, Nakasatien S, Tsoi TF, et al.
Endocrinology, diabetes & metabolism case reports 2022; (2022()).
PMID: 36106561
This page explains how HNF1B-MODY can affect the kidneys for informational purposes only and does not constitute medical advice. Your endocrinologist, nephrologist, or genetic counselor can interpret your individual results and monitoring needs.
Get notified when new evidence is published on MODY.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.